About Roche Diagnostics
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche’s personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients.
As one of the hubs of the Group’s diagnostics business, Roche Mannheim plays a central role. The Rhine-Neckar Metropolitan Region with its biotech clusters provides the company with an excellent research and development environment. Roche Mannheim is the third largest site in the Roche Group and one of the most diverse. It is a major operational hub for the Group’s Diagnostics Division and headquarters of the division’s Diabetes Care unit. Mannheim is also the location for Roche mtm laboratories AG, the manufacturer of innovative tests for early detection of cervical cancer and Roche Diagnostics Deutschland GmbH, Roche’s sales company in Germany for diagnostics and diabetes products. Activities at the site include research and development, production, strategic marketing and global logistics for the Diagnostics Division and production and packaging of finished biopharmaceuticals for Roche’s Pharmaceuticals Division. About 7,700 people were employed at the site.
© 2013 BioRN Cluster Management GmbH • All Rights Reserved • Contact & Legal Notice